|
Market Closed -
Other stock markets
|
After hours 04:23:22 pm | |||
| 6.990 USD | -3.59% |
|
7.105 | +1.65% |
| 08:10pm | Teladoc Health, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 03:45 PM | |
| Jan. 12 | Teladoc Health, Inc. Launches Enhanced 24/7 Care Service | CI |
| Capitalization | 1.29B 1.11B 1.03B 958M 1.79B 116B 1.93B 11.85B 4.66B 55.53B 4.83B 4.73B 205B | P/E ratio 2025 * |
-6.24x | P/E ratio 2026 * | -9.4x |
|---|---|---|---|---|---|
| Enterprise value | 1.63B 1.4B 1.31B 1.22B 2.27B 148B 2.45B 15.06B 5.92B 70.56B 6.13B 6.01B 260B | EV / Sales 2025 * |
0.65x | EV / Sales 2026 * | 0.59x |
| Free-Float |
99.19% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Teladoc Health, Inc.
| 1 day | -2.07% | ||
| 1 week | -12.56% | ||
| Current month | -0.07% | ||
| 1 month | -4.70% | ||
| 3 months | -15.21% | ||
| 6 months | -15.42% | ||
| Current year | -0.07% |
| 1 week | 6.99 |  | 8.06 |
| 1 month | 6.88 | | 8.06 |
| Current year | 6.94 | | 8.06 |
| 1 year | 6.35 | | 15.21 |
| 3 years | 6.35 | | 34.36 |
| 5 years | 6.35 | | 308 |
| 10 years | 6.35 | | 308 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Divita
CEO | Chief Executive Officer | 56 | 2024-06-09 |
Nikolaos Nanis
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jeff Nadler
CTO | Chief Tech/Sci/R&D Officer | - | 2011-02-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Tom McKinley
BRD | Director/Board Member | 74 | 2009-10-31 |
David Snow
CHM | Chairman | 71 | 2014-11-30 |
David Shedlarz
BRD | Director/Board Member | 76 | 2016-09-18 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.07% | -12.56% | -27.89% | -74.02% | 1.29B | |
| +0.40% | -9.11% | +24.44% | +328.02% | 7.36B | |
| +0.31% | +0.50% | - | - | 933M | |
| -0.88% | +0.89% | +36.85% | +427.19% | 661M | |
| -10.69% | -11.23% | -25.46% | +988.24% | 659M | |
| -3.73% | -10.51% | -44.41% | -93.92% | 81.2M | |
| -3.57% | -8.47% | -59.85% | -92.29% | 52.12M | |
| Average | -2.95% | -0.01% | -16.05% | +247.21% | 1.58B | |
| Weighted average by Cap. | -0.71% | -3.46% | +14.35% | +320.79% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.52B 2.17B 2.02B 1.88B 3.51B 228B 3.78B 23.24B 9.13B 109B 9.46B 9.27B 402B | 2.55B 2.19B 2.04B 1.9B 3.54B 230B 3.82B 23.48B 9.23B 110B 9.56B 9.36B 406B |
| Net income | -207M -177M -166M -154M -287M -18.65B -309M -1.9B -748M -8.91B -775M -759M -32.88B | -143M -123M -115M -107M -199M -12.95B -215M -1.32B -519M -6.19B -538M -527M -22.83B |
| Net Debt | 348M 299M 279M 259M 484M 31.45B 522M 3.21B 1.26B 15.03B 1.31B 1.28B 55.43B | 221M 190M 177M 164M 306M 19.92B 330M 2.03B 798M 9.52B 827M 810M 35.11B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-13 | 6.990 $ | -3.59% | 4,656,630 |
| 26-01-12 | 7.250 $ | -2.82% | 3,679,232 |
| 26-01-09 | 7.460 $ | -1.97% | 4,997,438 |
| 26-01-08 | 7.610 $ | +0.53% | 4,501,479 |
| 26-01-07 | 7.570 $ | -5.37% | 4,770,869 |
Delayed Quote Nyse, January 13, 2026 at 03:52 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TDOC Stock
Select your edition
All financial news and data tailored to specific country editions
